Is Sorrento Therapeutics, Inc. (NASDAQ:SRNE) a Good Investment?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) for the period of 9-Day stands at 51.09% while the stochastic %D for the same period stands at 60.44%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Sorrento Therapeutics, Inc. (NASDAQ:SRNE)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.

Previous Day Activity Analysis

On the last trading day, Sorrento Therapeutics, Inc. (NASDAQ:SRNE) opened the session at $2.8 and after going down -8.77% closed at $2.6. The stock lost -0.2 points in the last trade.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)’s stock fluctuated in the range of $2.55 and $2.95 during the previous active session. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) traded with the volume of 1.5 Million with average volume of 1.01 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 1.73 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.33 and 56.7 respectively.

Currently the Insider Ownership of the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is at 0.4% and the shares outstanding are 74.21 Million.

Important Ratio Analysis

Some important ratios to consider here for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are discussed below:

The Price to Sale P/S and Price to Book P/B shows the value of 12.21 and 1.98 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.55 and 0 correspondingly.

The Quick Ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stands at 0.8 while the Current Ratio depicts the value of 0.8.

Return on Assets ROA of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is at -9.9% whereas, Return on Equity ROE and Return of Investment ROI of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stand at -45% and -75.5% respectively.

Stock Performance Analysis

The stock performance of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) on the basis of 5 day trade show the dip of -29.73% whereas, the monthly performance of the stock shows increase of 48.57%.

The quarterly performance of the stock remained in green zone with the value of 26.83% while six month performance of the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) remained bullish with the count of 52.94%.

The yearly and YTD performance of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) remained down at -62.75% and -46.94% respectively.